Epigen Cardio LLC - PA Philadelphia, Philadelphia 19104

Epigen Cardio LLC entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Jonathan Epstein by calling (215) 898-8731 during business hours. You can also write to the business’ Single Location at 3160 Chestnut St # 200, Philadelphia, Pennsylvania PA 19104. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Epigen Cardio LLC
Representative: Jonathan Epstein
Place of Business: 3160 Chestnut St # 200, Philadelphia, PA 19104
Contact Number: (215) 898-8731
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2013
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Epigen Cardio LLC is a company operating from Philadelphia, Pennsylvania providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Epigen Cardio LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Jonathan Epstein at (215) 898-8731 for related queries, or to locate its Single Location using the coordinates 39.953553,-75.18659.

The Single Location can also be found at the street address 3160 Chestnut St # 200 in Philadelphia, Pennsylvania 19104 and can be engaged online through the company website at , the company Twitter , and Facebook page .